# FDA Inspection 1131381 - Janssen Biotech, Inc - September 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/26e4bfa6-01ed-4903-914c-acbf22d5cbe0
Source feed: FDA_Inspections

> FDA Inspection 1131381 for Janssen Biotech, Inc on September 14, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1131381
- Company Name: Janssen Biotech, Inc
- Inspection Date: 2020-09-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271223 - 2025-08-14](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/8cb9d246-c28c-4e2e-9a90-c89ec81c40e8)
- [FDA Inspection 1271223 - 2025-08-14](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/110fcfac-797e-477f-85d6-f92544f44fe0)
- [FDA Inspection 1229931 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/a957db33-ff2d-4e98-86e3-9332d9d2d54b)
- [FDA Inspection 1229931 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/921e9890-538b-4915-8657-233cf0045cb0)
- [FDA Inspection 1229931 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/a0a0206e-4d05-4a2c-99ac-eb3165e3c7cb)

Company: https://www.keypedia.com/companies/janssen-biotech-inc/7d87f794-c8cc-4a2c-b985-4d62ebc2d60b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c